Pediatric Hematology and Oncology

期刊简介：PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.

【译文】儿科血液病学和肿瘤学涵盖儿童血液病和恶性疾病研究及患者管理的各个方面。我们的目标是使《儿科血液病学和肿瘤学》成为国际临床医生和科学家共同致力于为患有癌症和血液病的儿童和青少年制定最佳治疗方案的首选期刊。该期刊支持针对不同临床环境的研究文章，以及提供对发病机制和/或临床护理新见解的杰出病例研究/系列，并欢迎突出联盟和会议中出现的发现和挑战的评论。关于癌症发病机制、遗传学、分子诊断、药理学、干细胞、分子靶向、细胞和免疫治疗以及移植的基础和转化研究报告也很有兴趣。关注支持性护理、晚期效应以及与这些领域的相关伦理、法律、心理、社会、文化或历史方面的论文也受到欢迎。欢迎对领域内重要发展的评论。来自国际儿科血液病学和肿瘤学界的科学家和临床医生的论文将被考虑发表。该期刊不依赖于或与任何组织或协会有关联。所有投稿在发表前都经过严格的同行评审。